Clinical Trials in Miami

Showing 2221-2240 of 11,431 trials

Single and Multiple Ascending Dose Study of AMG 133 in Participants With Obesity

NCT04478708

The study aims to assess the safety and tolerability of maridebart cafraglutide as single and multiple doses in participants with obesity

Obesity

Amgen110 participantsStarted Aug 2020

Anaheim, California, United States • Tustin, California, United States • Miami, Florida, United States

RECRUITINGPhase 2< 1 mile

CapTemY90 for Grade 2/3 NET Liver Metastases

NCT04339036

This is a Phase 2 evaluation of hepatic-progression free survival among patients with Grade 2 liver-dominant NET metastases undergoing combination therapy with CapTem and Y90 radioembolization.The hypothesis is to confirm safety and to assess if disease control is improved relative to expectation from either therapy alone. A Grade 3 arm was added in 2025.

Neuroendocrine Tumor Grade 2Neuroendocrine Tumors

Abramson Cancer Center at Penn Medicine70 participantsStarted Oct 2021

La Jolla, California, United States • Miami, Florida, United States • Buffalo, New York, United States +1 more locations

COMPLETEDPhase 1< 1 mile

An Investigational Study of ESK-001 in Participants With Normal Renal Function and Participants With Mild, Moderate, and Severe Impaired Renal Function

NCT06962774

This a phase 1, open label, single dose, parallel cohort study to determine the pharmacokinetics (PK) of study drug (ESK-001) in healthy volunteer participants, and participants with mild, moderate, and severe renal impairment.

Renal Impairment

Alumis Inc16 participantsStarted Apr 2025

Miami, Florida, United States • Miami Lakes, Florida, United States • Miami Lakes, Florida, United States +1 more locations

Single and Multiple Ascending Dose Study of AMG 133 in Participants With Obesity

CapTemY90 for Grade 2/3 NET Liver Metastases

An Investigational Study of ESK-001 in Participants With Normal Renal Function and Participants With Mild, Moderate, and Severe Impaired Renal Function

Find Trials by Condition in Miami

A Study to Assess Safety of ABBV-916 and How Intravenous ABBV-916 Moves Through Body and Affects Brain Amyloid Plaque Clearance in Adult Participants (Aged 50-90 Years) With Early Alzheimer's Disease

Study of BOTOX Injections in Prevention of Migraine in Adult Participants With Episodic Migraine

Study of Lifileucel (LN-144), Autologous Tumor Infiltrating Lymphocytes, in the Treatment of Patients With Metastatic Melanoma

MAGE A10ᶜ⁷⁹⁶T for Advanced NSCLC

Phase 1/2 Study of Silevertinib (BDTX-1535) in Patients With Glioblastoma or Non-Small Cell Lung Cancer With EGFR Mutations

Ceftibuten/VNRX-7145 in Participants With Varying Degrees of Renal Function

A Research Study Investigating Mim8 in Adults and Adolescents With Haemophilia A With or Without Inhibitors

AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma

An Adaptive Phase 2a/2b Study of LY3871801 in Adult Participants With Rheumatoid Arthritis

AB-101 in Combination With B-Cell Depleting mAb in Patients Who Failed Treatment for Class III or IV Lupus Nephritis or Other Forms of Refractory Systemic Lupus Erythematosus

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of IgPro20 in Adults With Dermatomyositis (DM)

A Phase 1b/2 Study of T-DXd Combinations in HER2-positive Metastatic Breast Cancer

Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy.

Lead EvaluAtion for Defibrillation and Reliability (LEADR) / Lead Evaluation for Defibrillation and Reliability in Left Bundle Branch Area Pacing (LEADR LBBAP)

A Clinical Trial of PR001 (LY3884961) in Patients With Peripheral Manifestations of Gaucher Disease (PROCEED)

Anal High-risk HPV, HSIL, and Microbiome Among Hispanic Peoples Living With HIV (PLWH)

An Expanded Access Protocol for Apalutamide Treatment of Participants With Non-Metastatic Castration-Resistant Prostate Cancer